Xartemis XR FDA Approval History
FDA Approved: Yes (Discontinued) (First approved March 11, 2014)
Brand name: Xartemis XR
Generic name: acetaminophen and oxycodone hydrochloride
Dosage form: Extended-Release Tablets
Company: Mallinckrodt Inc.
Treatment for: Pain
Marketing Status: Discontinued
Xartemis XR (acetaminophen and oxycodone hydrochloride) is an extended-release analgesic and opioid agonist formulation for the management of moderate to severe acute pain.
Development Timeline for Xartemis XR
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.